Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
VKTX Viking Therapeutics
- 28.870
- +0.200+0.70%
Close Feb 28 16:00 ET
- 28.920
- +0.050+0.17%
Post 20:01 ET
3.24BMarket Cap-28.58P/E (TTM)
29.290High28.040Low3.13MVolume28.110Open28.670Pre Close89.79MTurnover2.87%Turnover RatioLossP/E (Static)112.25MShares96.74052wk High3.68P/B3.15BFloat Cap27.20052wk Low--Dividend TTM109.09MShs Float99.410Historical High--Div YieldTTM4.36%Amplitude0.880Historical Low28.674Avg Price1Lot Size
Viking Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -19.64%-87.79M | -76.76%-31.18M | -11.72%-21.96M | -149.35%-28.51M | 75.11%-6.13M | -51.61%-73.38M | -61.45%-17.64M | -45.63%-19.66M | 14.93%-11.44M | -134.03%-24.64M |
| Net income from continuing operations | -28.02%-109.96M | -43.94%-35.42M | -10.68%-24.94M | -15.73%-22.25M | -40.06%-27.36M | -24.73%-85.9M | -25.80%-24.61M | -42.86%-22.53M | -10.29%-19.23M | -21.29%-19.53M |
| Operating gains losses | ---112K | ---1K | ---113K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 18.49%346K | 48.65%110K | 19.18%87K | 2.74%75K | 2.78%74K | 0.34%292K | 2.78%74K | -48.59%73K | --73K | -6.49%72K |
| Other non cash items | 0.76%132K | -2.78%35K | 175.00%33K | -37.21%27K | -7.50%37K | 31.00%131K | 80.00%36K | -76.92%12K | 258.33%43K | 150.00%40K |
| Change In working capital | 163.87%9.36M | -55.16%2.46M | -170.93%-1.03M | -259.62%-8.01M | 289.80%15.95M | -65.18%3.55M | -15.48%5.48M | 48,600.00%1.46M | 298.73%5.02M | -442.60%-8.4M |
| -Change in receivables | 273.52%1.2M | -539.60%-646K | 447.56%1.35M | -134.33%-157K | 169.55%655K | -47.72%321K | -187.83%-101K | 62.91%246K | -127.57%-67K | 131.43%243K |
| -Change in prepaid assets | -93.04%446K | 2,694.83%1.51M | -298.69%-2.73M | -101.07%-79K | 177.41%1.75M | 304.73%6.41M | 95.95%-58K | 66.83%1.37M | 388.95%7.35M | -9,917.39%-2.26M |
| -Change in payables and accrued expense | 386.49%8.12M | -69.86%1.73M | 677.92%445K | -253.26%-7.69M | 316.31%13.64M | -121.98%-2.83M | -27.38%5.72M | 91.10%-77K | -162.58%-2.18M | -362.56%-6.3M |
| -Change in other current liabilities | -15.85%-402K | -47.13%-128K | -10.34%-96K | -2.27%-90K | -3.53%-88K | -83.60%-347K | -3.57%-87K | 22.32%-87K | -206.02%-88K | -11.84%-85K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -19.64%-87.79M | -76.76%-31.18M | -11.72%-21.96M | -149.35%-28.51M | 75.11%-6.13M | -51.61%-73.38M | -61.45%-17.64M | -45.63%-19.66M | 14.93%-11.44M | -134.03%-24.64M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -208.99%-553.37M | -81.57%6.58M | 306.65%25.9M | 38.35%-126.06M | -21,018.65%-459.79M | -427.08%-179.09M | 392.19%35.73M | -146.61%-12.53M | -1,177.36%-204.48M | 35.76%2.2M |
| Net investment purchase and sale | -208.99%-553.37M | -81.57%6.58M | 306.65%25.9M | 38.35%-126.06M | -21,018.65%-459.79M | -427.08%-179.09M | 392.19%35.73M | -146.61%-12.53M | -1,177.36%-204.48M | 35.76%2.2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -208.99%-553.37M | -81.57%6.58M | 306.65%25.9M | 38.35%-126.06M | -21,018.65%-459.79M | -427.08%-179.09M | 392.19%35.73M | -146.61%-12.53M | -1,177.36%-204.48M | 35.76%2.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 125.69%612.46M | 431.91%1M | 3,508.11%2.52M | -98.91%2.91M | 14,384.63%606.04M | 6,418.76%271.38M | -98.25%188K | -840.00%-74K | 16,897.36%267.08M | 183.58%4.18M |
| Net common stock issuance | 121.34%597.09M | -2,269.63%-46.66M | 2,360.86%46.66M | -100.01%-25K | 1,613,935.14%597.12M | 4,057.17%269.76M | -6,053.13%-1.97M | 18,860.00%1.9M | 16,221.27%269.87M | 99.28%-37K |
| Proceeds from stock option exercised by employees | 59.77%10.81M | 431.91%1M | 252,300.00%2.52M | 12.05%2.93M | 9.96%4.36M | 698.11%6.77M | 25.33%188K | ---1K | 3,013.10%2.62M | 545.93%3.97M |
| Net other financing activities | 188.45%4.56M | 2,269.63%46.66M | -2,269.63%-46.66M | --0 | 1,687.06%4.56M | -150.85%-5.15M | -81.48%1.97M | ---1.97M | ---5.41M | 151.10%255K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 125.69%612.46M | 431.91%1M | 3,508.11%2.52M | -98.91%2.91M | 14,384.63%606.04M | 6,418.76%271.38M | -98.25%188K | -840.00%-74K | 16,897.36%267.08M | 183.58%4.18M |
| Net cash flow | ||||||||||
| Beginning cash position | 51.55%55.52M | 35.40%50.35M | -36.83%43.92M | 965.13%195.58M | 51.55%55.52M | 38.91%36.63M | 26.45%37.19M | 328.44%69.52M | 47.44%18.36M | 38.91%36.63M |
| Current changes in cash | -251.70%-28.69M | -229.08%-23.6M | 120.02%6.46M | -396.46%-151.67M | 867.27%140.11M | 79.81%18.91M | 158.10%18.28M | -340.70%-32.27M | 1,195.85%51.16M | -31.21%-18.26M |
| Effect of exchange rate changes | -393.33%-148K | -248.00%-74K | 57.35%-29K | 200.00%3K | -433.33%-48K | 88.37%-30K | -64.54%50K | 69.51%-68K | 98.30%-3K | ---9K |
| End cash Position | -51.95%26.68M | -51.95%26.68M | 35.40%50.35M | -36.83%43.92M | 965.13%195.58M | 51.55%55.52M | 51.55%55.52M | 26.45%37.19M | 328.44%69.52M | 47.44%18.36M |
| Free cash flow | -19.64%-87.79M | -76.76%-31.18M | -11.72%-21.96M | -149.35%-28.51M | 75.11%-6.13M | -51.61%-73.38M | -61.45%-17.64M | -45.63%-19.66M | 14.93%-11.44M | -134.03%-24.64M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |